NeuBase Therapeutics Inc Data Call Transcript
Greetings. Welcome to the NeuBase Therapeutics Investor Update Call. (Operator Instructions) Please note this conference is being recorded.
At this time, I'll turn the conference over to Todd Branning, Chief Financial Officer. Todd, you may now begin.
Thank you, moderator. Good morning, everyone, and welcome to NeuBase's investor update call. I'm Todd Branning, Chief Financial Officer at NeuBase.
I am joined today by Dr. Dietrich Stephan, our Chief Executive Officer; and Dr. Sandra Rojas-Caro, our Chief Medical Officer. During today's call, Dietrich will deliver introductory remarks and provide some general context, and Sandra will provide an update on our myotonic dystrophy type 1, or DM1, development program. Then we will open the call for your questions. We expect this call to last 45 minutes.
I would like to remind you that this call will contain remarks concerning NeuBase's future expectations, plans and prospects, which constitute forward-looking statements for the purposes of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
